Company intelligence / Profile preview

UPMC Enterprises

Pittsburgh, Pennsylvania, United Statesenterprises.upmc.com ↗
Ownership
Private
Development stage
Other
01

Overview

UPMC Enterprises serves as the innovation, commercialization, and venture capital division of UPMC. It develops and invests in digital health solutions, diagnostics, therapeutics—including gene therapies for retinal diseases and immunotherapies for cancer—and supports early-to-late stage growth companies. Its model has led to successful exits such as eVisit acquiring its teleconsult technology platform and Accuhealth merging with Signallamp. Recent clinical advances include progress at BlueSphere Bio, Cerevance, Mozart Therapeutics, Noema Pharma, SparingVision among others.

Therapeutic areas
OncologyOphthalmologyNeurology
Modalities
Gene therapyTCR T-cell therapyMonoclonal antibodySmall moleculeDigital health solutions/platforms
Industry
Investors
02

Partnerships

Roche (gene therapies via Avista Therapeutics partnership)Redesign Health (co-launcher of Glimmer Health)Academic partnerships with Carnegie Mellon University & University of Pittsburgh through PHDA alliance

Beyond the preview

Go deeper on UPMC Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UPMC Enterprises.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call